Hori M, Uzawa T, Morita K, Noda T, Takahashi H, Inoue J
Research Center, Toyo Jozo Co. Ltd., Shizuoka, Japan.
Bone Miner. 1988 Jan;3(3):193-9.
The effect of human PTH(1-34) on the development of osteopenia induced by ovariectomy was investigated in immature female Sprague-Dawley rats. After the surgery, human PTH(1-34) was injected subcutaneously three times a week for 25 weeks. A reduction of serum calcium level and a tendency to increased serum alkaline phosphatase activity were seen in ovariectomized rats. The ovariectomized rat bones were characterized by reduction of dry weight, ash weight, calcium content and phosphorus content, but there was no change in length, volume and ash content in these bones. Human PTH(1-34) prevented the reduction of dry weight, ash weight, calcium content and phosphorus content dose dependently (1.5-6.0 micrograms/kg) in ovariectomized rats. It was concluded that pulsatile administration of human PTH(1-34) prevented the development of osteopenia induced by ovariectomy.
在未成熟雌性斯普拉格-道利大鼠中研究了人甲状旁腺激素(1-34)对卵巢切除诱导的骨质减少发展的影响。手术后,每周皮下注射人甲状旁腺激素(1-34)三次,共25周。卵巢切除大鼠出现血清钙水平降低以及血清碱性磷酸酶活性升高的趋势。卵巢切除大鼠的骨骼表现为干重、灰重、钙含量和磷含量降低,但这些骨骼的长度、体积和灰分含量没有变化。人甲状旁腺激素(1-34)以剂量依赖性方式(1.5-6.0微克/千克)防止卵巢切除大鼠的干重、灰重、钙含量和磷含量降低。得出的结论是,脉冲式给予人甲状旁腺激素(1-34)可防止卵巢切除诱导的骨质减少的发展。